Addyi Flibanserin

Addyi (Flibanserin) is an FDA-approved prescription medication designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. Approved by the FDA in 2015, Addyi is often referred to as the "female libido pill." It works by balancing brain neurotransmitters to enhance sexual desire and reduce distress associated with low libido. Manufactured by Sprout Pharmaceuticals in the USA, Addyi is a groundbreaking solution for improving women's sexual health and overall well-being.